23 related articles for article (PubMed ID: 12388675)
1. Endomorphin analogues containing D-Pro2 discriminate different mu-opioid receptor mediated antinociception in mice.
Sakurada S; Watanabe H; Hayashi T; Yuhki M; Fujimura T; Murayama K; Sakurada C; Sakurada T
Br J Pharmacol; 2002 Dec; 137(8):1143-6. PubMed ID: 12466222
[TBL] [Abstract][Full Text] [Related]
2. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
3. Differential antinociception induced by spinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Nagase H; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2001 Aug; 298(2):592-7. PubMed ID: 11454920
[TBL] [Abstract][Full Text] [Related]
4. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
5. Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of mu-opioid receptor clone leads to differential loss of spinal endomorphin-1-and endomorphin-2-induced antinociception in the mouse.
Wu HE; Mizoguchi H; Terashvili M; Leitermann RJ; Hung KC; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 2002 Nov; 303(2):867-73. PubMed ID: 12388674
[TBL] [Abstract][Full Text] [Related]
6. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
[TBL] [Abstract][Full Text] [Related]
7. The antinociceptive properties of endomorphin-1 and endomorphin-2 in the mouse.
Tseng LF
Jpn J Pharmacol; 2002 Jul; 89(3):216-20. PubMed ID: 12184724
[TBL] [Abstract][Full Text] [Related]
8. Differential antinociceptive effects induced by intrathecally-administered endomorphin-1 and endomorphin-2 in mice.
Sakurada S; Hayashi T; Yuhki M
Jpn J Pharmacol; 2002 Jul; 89(3):221-3. PubMed ID: 12184725
[TBL] [Abstract][Full Text] [Related]
9. [Development of a new analgesic based on metabolism of endomorphin, an endogenous opioid peptide].
Sakurada C
Yakugaku Zasshi; 2004 Aug; 124(8):549-54. PubMed ID: 15297724
[TBL] [Abstract][Full Text] [Related]
10. Exploiting endogenous opioids: Lessons learned from endomorphin 2 in the female rat.
Gintzler AR; Liu NJ; Storman EM; Wessendorf MW
Peptides; 2019 Feb; 112():133-138. PubMed ID: 30557590
[TBL] [Abstract][Full Text] [Related]
11. D-pro(2)-endomorphin-1 and D-pro(2)-endomorphin-2, respectively, attenuate the antinociception induced by endomorphin-1 and endomorphin-2 given intrathecally in the mouse.
Hung KC; Wu HE; Mizoguchi H; Sakurada S; Okayama T; Fujimura T; Murayama K; Sakurada T; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 2002 Nov; 303(2):874-9. PubMed ID: 12388675
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
